Serum H-FABP levels in patients with hypothyroidism

Gunes F., Asik M., Temiz A., Vural A., Sen H., Binnetoglu E., ...More

WIENER KLINISCHE WOCHENSCHRIFT, vol.126, pp.727-733, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 126
  • Publication Date: 2014
  • Doi Number: 10.1007/s00508-014-0612-7
  • Journal Name: WIENER KLINISCHE WOCHENSCHRIFT
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.727-733
  • Çanakkale Onsekiz Mart University Affiliated: Yes

Abstract

Hypothyroidism (HT) has an increased risk for cardiovascular mortality and morbidity due to increased atherosclerosis. Heart-type fatty acid binding protein (H-FABP) is abundant in the cytosol of cardiomyocytes, and transports fatty acids into these cells. Although H-FABP has been shown to increase in several atherosclerotic and inflammatory conditions, there is no literature data indicating an alteration in other atherosclerotic processes such as HT.